Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Millicom International Cellular S.A. Common Stock (TIGO) vs UnitedHealth Group Inc (UNH) Price & Performance

Millicom International Cellular S.A. Common StockTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Millicom International Cellular S.A. Common Stock vs UnitedHealth Group Inc — how do they compare? Millicom International Cellular S.A. Common Stock trades at $80.27 (market cap $13.34B), while UnitedHealth Group Inc trades at $398.98 (market cap $339.08B). The key difference: UnitedHealth Group Inc is far larger — about 25.4× Millicom International Cellular S.A. Common Stock's market cap, and Millicom International Cellular S.A. Common Stock pays the higher dividend (3.77%). Which is the better fit depends on your goals — on Pluang, investors hold Millicom International Cellular S.A. Common Stock for 0 Days and UnitedHealth Group Inc for 98 Days on average.

TIGOUNH
Market Cap
$13.34B$339.08B
Volume
1,586,68412,648,635
Sector
MediaHealth
52-Week High
$104.31$436.35
52-Week Low
$45.81$259.02
Typical Hold Time
0 Days98 Days
Enterprise Value
$24.38B$380.94B
Dividend Yield
3.77%2.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Millicom International Cellular S.A. Common Stock

TIGO trades at $79.54, down 0.92% on the day, with a neutral technical signal and key support at $79. The company reported strong 2025 results with $5.82B revenue and $1.32B net income, but 2026 earnings have missed expectations in two of the last three quarters. Recent news highlights its addition to Zacks' Strong Buy list and a consistent $0.75 quarterly dividend.

The stock offers a 12.9% upside to the consensus price target of $89.78, supported by solid profitability and cash flow, but faces risks from earnings volatility and high debt. Analyst sentiment is mixed with a Hold consensus, suggesting cautious optimism amid integration challenges from recent acquisitions.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $378.52, down 0.21% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with consistent earnings beats in recent quarters, including Q3 2026 EPS of $4.69 beating expectations of $4.14. Revenue growth remains solid at $447.57B for 2025, though net margins have compressed to 3.14%. Recent developments include strategic moves with TPG for WellMed operations and continued AI investments in Optum Insight.

UNH presents a compelling investment case with 82.7% analyst buy ratings and a $470.11 consensus price target representing 24% upside. The company's Medicare Advantage strength and Optum improvements support growth, though regulatory scrutiny and medical cost pressures remain key risks. Strong institutional ownership and Michael Burry's recent call option position signal confidence in the turnaround story.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TIGO
100% Buy0% Sell
Avg holding period · 0 Days
UNH
30% Buy70% Sell
Avg holding period · 98 Days

Top news

Latest headlines on both assets

About Millicom International Cellular S.A. Common Stock

Millicom International Cellular S.A. operates telecommunications and digital services under the Tigo brand across Latin America, providing mobile, fiber broadband, and pay-TV services. The company also offers mobile financial services through its Tigo Money business.

Read more on TIGO →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →